<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38813442</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>The prevalence of long COVID in people with diabetes mellitus-evidence from a UK cohort.</ArticleTitle><Pagination><StartPage>102607</StartPage><MedlinePgn>102607</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102607</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2024.102607</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">It was apparent from the early phase of the SARS-CoV-2 virus (COVID-19) pandemic that a multi-system syndrome can develop in the weeks following a COVID-19 infection, now referred to as Long COVID. Given that people living with diabetes are at increased risk of hospital admission/poor outcomes following COVID-19 infection we hypothesised that they may also be more susceptible to developing Long COVID. We describe here the prevalence of Long COVID in people living with diabetes when compared to matched controls in a Northwest UK population.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This was a retrospective cohort study of people who had a recorded diagnosis of type 1 diabetes (T1D) or type 2 diabetes (T2D) who were alive on 1st January 2020 and who had a proven COVID-19 infection. We used electronic health record data from the Greater Manchester Care Record collected from 1st January 2020 to 16th September 2023, we determined the prevalence of Long COVID in people with T1D and T2D vs matched individuals without diabetes (non-DM).</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">There were 3087 T1D individuals with 14,077 non-diabetes controls and 3087 T2D individuals with 14,077 non-diabetes controls and 29,700 T2D individuals vs 119,951 controls. For T1D, there was a lower proportion of Long COVID diagnosis and/or referral to a Long COVID service at 0.33% vs 0.48% for matched controls. The prevalence of Long COVID In T2D individuals was 0.53% vs 1:3 matched controls 0.54%. For T2D, there were differences by sex in the prevalence of Long COVID in comparison with 1:3 matched controls. For Long COVID between males with T2D and their matched controls, the prevalence was lower in matched controls at 0.46%.vs 0.54% (0.008). When considering the prevalence of LC between females with T2D and their matched controls, the prevalence was higher in matched controls at 0.61% vs 0.53% (0.007). The prevalence of Long COVID in males with T2D vs females was not different. T2D patients at older vs younger age were at reduced risk of developing Long COVID (OR 0.994 [95% CI) [0.989, 0.999]). For females there was a minor increase of risk (OR 1.179, 95% CI [1.002, 1.387]). Presence of a higher body mass index (BMI) was also associated an increased risk of developing Long COVID (OR 1.013, 95% CI [1.001, 1.026]). The estimated general population prevalence of Long COVID based on general practice coding (not self-reported) of this diagnosis was 0.5% of people with a prior acute COVID-19 diagnosis.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Recorded Long COVID was more prevalent in men with T2D than in matched non-T2D controls with the opposite seen for T2D women, with recorded Long COVID rates being similar for T2D men and women. Younger age, female sex and higher BMI were all associated with a greater likelihood of developing Long COVID when taken as individual variables. There remains an imperative for continuing awareness of Long COVID as a differential diagnosis for multi-system symptomatic presentation in the context of a previous acute COVID-19 infection.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">The time of co-author RW was supported by the NIHR Applied Research Collaboration Greater Manchester (NIHR200174) and the NIHR Manchester Biomedical Research Centre (NIHR203308).</AbstractText><CopyrightInformation>&#xa9; 2024 Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heald</LastName><ForeName>Adrian H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>The School of Medicine and Manchester Academic Health Sciences Centre, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Greater Manchester, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Greater Manchester, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Primary Care &amp; Health Services Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Donal O'Donoghue Renal Research Centre, Northern Care Alliance Research &amp; Innovation, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakerly</LastName><ForeName>Nawar Diar</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Division of Informatics, Imaging and Data Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Salford Royal Hospital, Salford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biological Sciences, Manchester Metropolitan University, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mccay</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ollier</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Type 121 diabetes</Keyword></KeywordList><CoiStatement>No author has any conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>30</Day><Hour>4</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38813442</ArticleId><ArticleId IdType="pmc">PMC11133790</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102607</ArticleId><ArticleId IdType="pii">S2589-5370(24)00186-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. The impact of vaccination programmes and their timing will have had a differential impact on this depending on geographical location. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J&#xa0;Infect Dis. 2022;226(9):1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Heald A.H., Jenkins D.A., Williams R., et al. The risk factors potentially influencing hospital admission in people with diabetes, following SARS-CoV-2 infection: a population-level analysis. Diabetes Ther. 2022;13:1007&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8944405</ArticleId><ArticleId IdType="pubmed">35325361</ArticleId></ArticleIdList></Reference><Reference><Citation>Heald A.H., Jenkins D.A., Williams R., et al. Mortality in people with type 2 diabetes following SARS-CoV-2 infection: a population level analysis of potential risk factors. Diabetes Ther. 2022;13:1037&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006208</ArticleId><ArticleId IdType="pubmed">35416588</ArticleId></ArticleIdList></Reference><Reference><Citation>Heald A.H., Jenkins D.A., Williams R., et al. CVD-COVID-UK/COVID-IMPACT Consortium Sars-Cov-2 infection in people with type 1 diabetes and hospital admission: an analysis of risk factors for England. Diabetes Ther. 2023;14:2031&#x2013;2042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10597906</ArticleId><ArticleId IdType="pubmed">37620452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippisley-Cox J., Coupland C.A., Mehta N., et al. Risk prediction of COVID-19 related death and hospital admission in adults after COVID-19 vaccination: national prospective cohort study. BMJ. 2021;374:n2244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8446717</ArticleId><ArticleId IdType="pubmed">34535466</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R., Riste L., Hann M., Walther A., Mukherjee A., Heald A. Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses. 2020;144</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO clinical case definition working group on post-COVID-19 condition. A clinical case definition of post-COVID-19 condition by a delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., et al. Characterising Long COVID: a living systematic review. BMJ Glob Health. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V. Long COVID-19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15:145&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadeh F.H., W Dolan S.A., Jarman B., Bajekal M., Davies P.M., Hart D. Measuring disadvantage: changes in the underprivileged area, Townsend, and Carstairs scores 1981-91. J Epidemiol Community Health. 1995;49 Suppl 2(Suppl 2):S30&#x2013;S33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1060873</ArticleId><ArticleId IdType="pubmed">8594131</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafi M.B., Javanmard S.H. Post-COVID-19 syndrome mechanisms, prevention and management. Int J Prev Med. 2023;14:59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10284243</ArticleId><ArticleId IdType="pubmed">37351054</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock C., Hassanein M., Khan E.G., et al. Diabetes and COVID-19: short- and long-term consequences. Horm Metab Res. 2022;54(8):503&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363150</ArticleId><ArticleId IdType="pubmed">35724689</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Misra A. Post COVID-19 syndrome (&#x201c;Long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr. 2021;15(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.visitnorthwest.com/population/greater-manchester</Citation></Reference><Reference><Citation>https://gmwearebettertogether.com/gm-care-record/</Citation></Reference><Reference><Citation>https://healthinnovationmanchester.com/thegmcarerecord/the-gm-care-record-for-secondary-uses-research</Citation></Reference><Reference><Citation>Vandenbroucke J.P., von Elm E., Altman D.G., et al. STROBE initiative. Strengthening the reporting of observational studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2020496</ArticleId><ArticleId IdType="pubmed">17941715</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.J., MacKenna B., Inglesby P., et al. The OpenSAFELY Collaborative) Clinical coding of Long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021;71(712):e806&#x2013;e814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.adruk.org/fileadmin/uploads/adruk/Documents/Data_Insights/Clinical_coding_and_capture_of_Long_COVID_V.3.4.pdf</Citation></Reference><Reference><Citation>Dolan S.A., Jarman B., Bajekal M., Davies P.M., Hart D. Measuring disadvantage: changes in the underprivileged area, Townsend, and Carstairs scores 1981-91. J&#xa0;Epidemiol Community Health. 1995;49 Suppl 2(Suppl 2):S30&#x2013;S33. doi: 10.1136/jech.49.suppl_2.s30. PMID: 8594131; PMCID: PMC1060873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech.49.suppl_2.s30</ArticleId><ArticleId IdType="pmc">PMC1060873</ArticleId><ArticleId IdType="pubmed">8594131</ArticleId></ArticleIdList></Reference><Reference><Citation>https://datadictionary.nhs.uk/data_elements/ethnic_category.html</Citation></Reference><Reference><Citation>Heald A.H., Jenkins D.A., Chaudhury N., et al. Application of a city wide digital population database for outcome analysis in diabetes: SARS-CoV-2, diabetes and hospital admission rate month by month in Greater Manchester, UK. Cardiovasc Endocrinol Metab. 2022;11(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805797</ArticleId><ArticleId IdType="pubmed">35128337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Arora I., Hsia D.S., et al. New-onset diabetes after COVID-19. J Clin Endocrinol Metab. 2023 Oct 18;108(11):e1164&#x2013;e1174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11009784</ArticleId><ArticleId IdType="pubmed">37207448</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., et al. Symptoms and risk factors for Long COVID in non-hospitalized adults. Nat Med. 2022;28:1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;6151. e0258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics. ons.gov.uk</Citation></Reference><Reference><Citation>https://www.ons.gov.uk/visualisations/areas/E08000007/</Citation></Reference><Reference><Citation>https://www.england.nhs.uk/wp-content/uploads/2022/07/C1607_The-NHS-plan-for-improving-Long-COVID-services_July-2022.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>